Literature DB >> 29096744

Hyperandrogenism stimulates inflammation and promote apoptosis of cumulus cells.

F Xu1, R Liu1, X Cao1.   

Abstract

To explore roles of androgen and cytokines such as IL-1, IL-6 and TNF-α in PCOS. Cumulus cells were isolated from rat COCs and divided into two sets of experiments. Set 1 includes 4 groups: Control group, IL-1 group (final concentration at 5 nM), IL-6 group (final concentration at 5nM) and TNF-α group (final concentration at 5nM). Set 2 also include 4 groups: Control group, Androgen group 1 (final concentration at 1 nM), Androgen group 2 (final concentration at 10 nM) and Androgen group 3 (final concentration at 100 nM). Androgen, at final concentration of 100 nM, can induce secretion of cytokines include IL-1, IL-6 and TNF-α in cumulus cells. This in turn leads to cell apoptosis probably through ROS production as well as promotes oocyte maturation. Androgen and cytokines that developed during PCOS contribute to ROS production, apoptosis and oocyte maturation in that disease.

Entities:  

Keywords:  Androgen; Apoptosis; Cytokine; Oocyte maturation.; PCOS; ROS

Mesh:

Substances:

Year:  2017        PMID: 29096744     DOI: 10.14715/cmb/2017.63.10.10

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  2 in total

1.  Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics.

Authors:  Xiushen Li; Jingxin Ma; Li Guo; Chenle Dong; Guli Zhu; Wenli Hong; Can Chen; Hao Wang; Xueqing Wu
Journal:  Oxid Med Cell Longev       Date:  2022-04-28       Impact factor: 7.310

2.  WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs.

Authors:  Mengxiong Li; Zhi Zeng; Aiqing Zhang; Qingjian Ye; Shujun Su; Tingting Xia
Journal:  Int J Gen Med       Date:  2021-11-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.